Despite medical advancements, a survey indicates that one-third of HIV-negative millennials still avoid physical contact with HIV-positive individuals. The discussion shifts to the high cost of Truvada, noting that a month's supply can cost $2,000 without insurance. The hosts question why life-saving preventative drugs are not provided for free if the goal is to "flatten the curve."